NL-OMON34509已完成不适用
Randomized trial to study the efficacy and adverse effects of the subcutaneous ICD in patients with a class I or IIa indication for ICD without an indication for pacing - Sub-ICD
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 208
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Class I or IIa indication for ICD
排除标准
- •Indication for pacing therapy
研究者
相似试验
进行中（未招募）
1 期
A study to investigate the efficacy and safety of L19TNF in previously treated patients with advanced stage or metastatic soft-tissue sarcomaEUCTR2018-004104-19-DEPhilogen S.p.A.98
进行中（未招募）
1 期
A study to investigate the efficacy and safety of L19TNF in previously treated patients with advanced stage or metastatic soft-tissue sarcomanresectable and/or metastatic soft-tissue sarcoma after failure of at least two prior systemic therapy regimensMedDRA version: 20.0Level: PTClassification code 10075333Term: Soft tissue sarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-004104-19-ESPhilogen S.p.A.98
进行中（未招募）
1 期
A study to investigate the efficacy and safety of L19TNF in previously treated patients with advanced stage or metastatic soft-tissue sarcomaEUCTR2018-004104-19-ITPHILOGEN S.P.A.98
进行中（未招募）
1 期
A study to investigate the efficacy and safety of L19TNF in previously treated patients with advanced stage or metastatic soft-tissue sarcomaEUCTR2018-004104-19-PLPhilogen S.p.A.98
进行中（未招募）
1 期
Efficacy and Safety of L19TNF in Previously Treated Patients With Advanced Stage or Metastatic Soft-tissue Sarcomanresectable and/or metastatic soft-tissue sarcoma after failure of at least two prior systemic therapy regimens.MedDRA version: 20.0Level: PTClassification code: 10075333Term: Soft tissue sarcoma Class: 100000004864CTIS2024-512704-20-00Philogen S.p.A.98